Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepantivir clinical trial in chronic hepatitis B
PACTR201507001055177Not yet recruiting
- Sponsor
- Bolar Pharmaceuticals
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tenofovir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Bolar Pharmaceuticals. Planned start May 2015; status: not yet recruiting.
02
Drugs
tenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on PACTR201507001055177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201507001055177.